Loading…
Psyence Biomedical Ltd. is projected to rise to $4.68 by 2027, a +49% move from its current price of $3.15. PBM is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $3.01 | $3.15 | $3.30 | +0.05% |
| Aug 6 | $2.95 | $3.15 | $3.37 | +0.09% |
| Aug 7 | $2.91 | $3.15 | $3.42 | +0.14% |
| Aug 8 | $2.87 | $3.16 | $3.47 | +0.19% |
| Aug 9 | $2.84 | $3.16 | $3.51 | +0.23% |
| Aug 10 | $2.82 | $3.16 | $3.54 | +0.28% |
| Aug 11 | $2.79 | $3.16 | $3.58 | +0.32% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.79 | $3.16 | $3.58 | +0.32% |
| Week 2 | $2.66 | $3.17 | $3.78 | +0.65% |
| Week 3 | $2.57 | $3.18 | $3.94 | +0.98% |
| Week 4 | $2.49 | $3.19 | $4.09 | +1.30% |
| Week 5 | $2.43 | $3.20 | $4.22 | +1.63% |
| Week 6 | $2.37 | $3.21 | $4.35 | +1.96% |
| Week 7 | $2.32 | $3.22 | $4.47 | +2.29% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
PBM is the stock symbol for Psyence Biomedical Ltd., an integrated biopharmaceutical company focused on botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada, and Psyence Biomedical Ltd.
is a subsidiary of Psyence Group Inc.
PBM trades at $3.36 per share and has a market capitalization of $11.37M. It ranks 5409 by market value in the broader market. The current price sits within a forecast that envisions gradual upside over time, with the average price in 2026 at $3.36 and higher-average years thereafter, culminating in a multi-year uptrend that includes substantial upside potential by 2040 and 2050.
A major floor 24.8% below — a decisive break under it would weaken the trend.
The nearest floor, 14.0% below — buyers have tended to step in here.
The nearest ceiling, 6.7% above — a clean break opens room to run.
A major ceiling 258.7% above — clearing it would confirm fresh momentum.
Key PBM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PBM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.14 | Buy | $3.15 | Buy |
| MA 10 | $3.07 | Buy | $3.09 | Buy |
| MA 20 | $3.02 | Buy | $3.09 | Buy |
| MA 50 | $3.31 | Sell | $3.64 | Sell |
| MA 100 | $3.88 | Sell | $11.75 | Sell |
| MA 200 | $27.69 | Sell | $613.04 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.74 | Neutral |
| Stoch RSI (14) | 70.41 | Neutral |
| CCI (20) | 94.00 | Neutral |
| Williams %R (14) | -35.19 | Info |
| MACD (12,26,9) | 0.06 | Buy |
| ROC (12) | 9.69 | Buy |
| Bollinger %B (20,2) | 0.79 | Neutral |
| Stochastic %K (14) | 64.81 | Neutral |
| TRIX (15) | -0.51 | Sell |
| Awesome (5,34) | 0.11 | Buy |
| Ultimate (7,14,28) | 57.94 | Neutral |
| Momentum (10) | 0.10 | Buy |
| Aroon Osc (25) | 96.00 | Buy |
| Hull MA (9) | 3.24 | Sell |
| ADX (14) | 15.37 | Neutral |
| ATR (14) | 0.14 | Info |
Technical sentiment is BULLISH. The RSI(14) is 60, and the near-term trend shows price action around the $3.36 level with a 50-day simple moving average at $3.33.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.23 | $3.15 | $4.83 | 0% | Neutral | |
| $3.49 | $4.68 | $6.75 | +49% | Bullish | |
| $3.41 | $4.82 | $7.37 | +53% | Bullish | |
| $2.93 | $4.33 | $6.93 | +37% | Bullish | |
| $2.87 | $4.41 | $7.33 | +40% | Bullish | |
| $2.54 | $4.06 | $6.96 | +29% | Bullish | |
| $2.46 | $4.07 | $7.18 | +29% | Bullish | |
| $3.20 | $5.47 | $9.90 | +74% | Bullish | |
| $3.25 | $5.72 | $10.60 | +82% | Bullish | |
| $3.28 | $5.98 | $11.31 | +90% | Bullish | |
| $3.46 | $7.30 | $15.08 | +132% | Bullish | |
| $4.53 | $10.08 | $23.17 | +220% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $2.23 | $3.15 | $3.91 | +0.00% |
| September 2026 | $2.78 | $3.35 | $4.21 | +6.46% |
| October 2026 | $2.69 | $3.29 | $4.20 | -2.02% |
| November 2026 | $2.68 | $3.30 | $4.28 | +0.53% |
| December 2026 | $2.95 | $3.68 | $4.83 | +11.35% |
Click any year to see its month-by-month PBM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, PBM could reach as high as $4.83, with a base case around $3.15 and support toward $2.23 — roughly 0% from $3.15. Price action looks broadly range-bound.
Expect PBM to range from $3.49 to $6.75 through 2027. The $4.68 average target implies a +49% move from current prices. That is up +49% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The PBM price prediction for 2028 points to an average of $4.82 (low $3.41, high $7.37) — a potential gain of +53% on today's $3.15. Momentum favours further upside here.
In 2029, PBM is projected to trade between $2.93 and $6.93, averaging $4.33 — a potential gain of +37% from today's $3.15. That is -10% versus the projected 2028 average. Buyers look set to stay in control over this stretch.
Psyence Biomedical Ltd.'s 2030 outlook centres on $4.41, within a $2.87 to $7.33 range. That is up +2% on the projected 2029 average. That marks a +40% change versus current levels. Momentum favours further upside here.
By 2031, PBM could reach as high as $6.96, with a base case around $4.06 and support toward $2.54 — roughly +29% from $3.15. Buyers look set to stay in control over this stretch.
Expect PBM to range from $2.46 to $7.18 through 2032. The $4.07 average target implies a +29% move from current prices. That is up 0% on the projected 2031 average. Momentum favours further upside here.
The PBM price prediction for 2033 points to an average of $5.47 (low $3.20, high $9.90) — a potential gain of +74% on today's $3.15. Buyers look set to stay in control over this stretch.
In 2034, PBM is projected to trade between $3.25 and $10.60, averaging $5.72 — a potential gain of +82% from today's $3.15. That is up +5% on the projected 2033 average. Momentum favours further upside here.
Psyence Biomedical Ltd.'s 2035 outlook centres on $5.98, within a $3.28 to $11.31 range. That is up +4% on the projected 2034 average. That marks a +90% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, PBM could reach as high as $15.08, with a base case around $7.30 and support toward $3.46 — roughly +132% from $3.15. Momentum favours further upside here.
Expect PBM to range from $4.53 to $23.17 through 2050. The $10.08 average target implies a +220% move from current prices. That is up +38% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in PBM today (≈ 317.460317 PBM) could be worth
$3,198.68
+$2,198.68 (+220%) by 2050 · US Dollar
Based on the average projected PBM price of $10.08 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PBMwould be worth at today's price.
$1,000 invested in PBM on Jul 31, 2025 (≈ 5.089463 PBM) would be worth
$16.03
-$983.97 (-98.4%) today · 0.02× · US Dollar
Based on a PBM entry price of $196.48 vs. today's $3.15.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.95 | $1,067.8 | +6.8% |
| 1 month ago | $3.11 | $1,012.86 | +1.3% |
| 3 months ago | $6.25 | $504 | -49.6% |
| 6 months ago | $3.8 | $828.95 | -17.1% |
| 1 year ago | $196.48 | $16.03 | -98.4% |
| All time (4.6y) ago | $232,031.25 | $0.01 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PBM forecast.
Our base-case forecast reaches $6.30 around 2040.
Implied market cap at $6.30: $24.03M
The multi-year forecast depicts ongoing upside, with 2027 expecting an average price of $4.98 and a max of $7.22, yielding a 48.4% ROI. The trajectory continues with 2028 an average of $5.16 and a max of $7.92 (53.5% ROI), and 2029 a $4.66 average with a $7.49 max (38.8% ROI). By 2030 the forecast shows an average of $4.69 with a max of $7.82 (39.5% ROI), and 2040 an average of $7.81 with a max of $16.22 (132.5% ROI).
The long-term view extends to 2050, with an average of $10.88 and a max of $25.03 (223.9% ROI). The lead NPX-5 program in Phase IIb for cancer patients in a palliative care setting is noted as a potential driver, while annualized volatility of 90% underscores the high uncertainty and risk surrounding these projections.
Tap a question to reveal the answer.
The forecasted avg price for 2030 is $4.69, with a min of $3.04 and a max of $7.82. The projected ROI is 39.5% and the sentiment is BULLISH.
The forecast shows bullish sentiment in multiple years beyond 2026, with positive ROI in 2027 (48.4%), 2028 (53.5%), 2029 (38.8%), and continuing gains through 2040 (132.5%) and 2050 (223.9%). These are estimates and not guarantees.
Yes. In 2033 the max forecast is $10.60, and the 2033 average is $5.83 with a min of $3.40. The ROI for 2033 is 73.6%.
PBM's current price is $3.36 and its market capitalization is $11.37M.
The 30-day range is from $2.46 to $4.59.
Psyence Biomedical Ltd. Community Discussion
0Share your Psyence Biomedical Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.